BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 2001;1552:61-85. [PMID: 11825687 DOI: 10.1016/s0304-419x(01)00037-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 77] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kim JY, Bae BN, Kim KS, Shin E, Park K. Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma. Cancer Res Treat 2009;41:29-35. [PMID: 19688069 DOI: 10.4143/crt.2009.41.1.29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
3 Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, Guarino V, Castellone MD, Di Benedetto M, Galli V, Motta S. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer. 2007;97:1545-1551. [PMID: 17987038 DOI: 10.1038/sj.bjc.6604070] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
4 Zhang G, He B, Weber GF. Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer. Mol Cell Biol 2003;23:6507-19. [PMID: 12944477 DOI: 10.1128/MCB.23.18.6507-6519.2003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
5 Suzuki M, Mose E, Galloy C, Tarin D. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. Am J Pathol 2007;171:682-92. [PMID: 17620367 DOI: 10.2353/ajpath.2007.070232] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
6 Elshafae SM, Dirksen WP, Alasonyalilar-Demirer A, Breitbach J, Yuan S, Kantake N, Supsavhad W, Hassan BB, Attia Z, Alstadt LB, Rosol TJ. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis. Prostate 2020;80:698-714. [PMID: 32348616 DOI: 10.1002/pros.23983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gao C, Mi Z, Guo H, Kuo PC. Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells. Neoplasia 2007;9:699-706. [PMID: 17898865 DOI: 10.1593/neo.07463] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
8 Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood 2008;111:3200-10. [PMID: 18184868 DOI: 10.1182/blood-2007-10-119099] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 8.4] [Reference Citation Analysis]
9 Menicali E, Moretti S, Voce P, Romagnoli S, Avenia N, Puxeddu E. Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma. Front Endocrinol (Lausanne) 2012;3:67. [PMID: 22661970 DOI: 10.3389/fendo.2012.00067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
10 Sampayo-Escobar V, Green R, Cheung MB, Bedi R, Mohapatra S, Mohapatra SS. Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection. PLoS One 2018;13:e0192709. [PMID: 29677209 DOI: 10.1371/journal.pone.0192709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jithesh PV, Risk JM, Schache AG, Dhanda J, Lane B, Liloglou T, Shaw RJ. The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 2013;108:370-9. [PMID: 23287992 DOI: 10.1038/bjc.2012.568] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
12 Fu X, Yao M, Ye C, Fang T, Wu R. Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis through the PI3K Pathway : Osteopontin Regulates Endometrial Cell Migration in Endometriosis. Reprod Sci 2021;28:435-46. [PMID: 32909189 DOI: 10.1007/s43032-020-00301-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Khan SA, Cook AC, Kappil M, Günthert U, Chambers AF, Tuck AB, Denhardt DT. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis 2005;22:663-73. [PMID: 16691370 DOI: 10.1007/s10585-006-9007-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
14 Selkirk SM, Morrow J, Barone TA, Hoffer A, Lock J, DeChant A, Mangla S, Plunkett RJ, Miller RH. Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal. J Neurooncol 2008;86:285-96. [PMID: 17928956 DOI: 10.1007/s11060-007-9477-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhang H, Ye QH, Ren N, Zhao L, Wang YF, Wu X, Sun HC, Wang L, Zhang BH, Liu YK. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2006;132:709-717. [PMID: 16786357 DOI: 10.1007/s00432-006-0119-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
16 Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer. 2008;8:212-226. [PMID: 18292776 DOI: 10.1038/nrc2345] [Cited by in Crossref: 305] [Cited by in F6Publishing: 291] [Article Influence: 21.8] [Reference Citation Analysis]
17 Kalra S, Gupta P, Tripathi T, Rai P. External apical root resorption in orthodontic patients: molecular and genetic basis. J Family Med Prim Care 2020;9:3872-82. [PMID: 33110782 DOI: 10.4103/jfmpc.jfmpc_802_20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kiss T, Ecsedi S, Vizkeleti L, Koroknai V, Emri G, Kovács N, Adany R, Balazs M. The role of osteopontin expression in melanoma progression. Tumour Biol 2015;36:7841-7. [PMID: 25944164 DOI: 10.1007/s13277-015-3495-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
19 Trotter TN, Li M, Pan Q, Peker D, Rowan PD, Li J, Zhan F, Suva LJ, Javed A, Yang Y. Myeloma cell-derived Runx2 promotes myeloma progression in bone. Blood 2015;125:3598-608. [PMID: 25862559 DOI: 10.1182/blood-2014-12-613968] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
20 Amilca-Seba K, Sabbah M, Larsen AK, Denis JA. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers (Basel) 2021;13:3793. [PMID: 34359694 DOI: 10.3390/cancers13153793] [Reference Citation Analysis]
21 Thomas LE, Winston J, Rad E, Mort M, Dodd KM, Tee AR, McDyer F, Moore S, Cooper DN, Upadhyaya M. Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours. Hum Genomics 2015;9:3. [PMID: 25884485 DOI: 10.1186/s40246-015-0025-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
22 Erb U, Megaptche AP, Gu X, Büchler MW, Zöller M. CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells. J Hematol Oncol 2014;7:29. [PMID: 24684724 DOI: 10.1186/1756-8722-7-29] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
23 Jain A, Karadag A, Fisher LW, Fedarko NS. Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2. Biochemistry 2008;47:10162-70. [PMID: 18729384 DOI: 10.1021/bi801068p] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
24 Friedmann-Morvinski D, Bhargava V, Gupta S, Verma IM, Subramaniam S. Identification of therapeutic targets for glioblastoma by network analysis. Oncogene 2016;35:608-20. [PMID: 25961929 DOI: 10.1038/onc.2015.119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhang GX, Zhao ZQ, Wang HD, Hao B. Enhancement of osteopontin expression in HepG2 cells by epidermal growth factor via phosphatidylinositol 3-kinase signaling pathway. World J Gastroenterol 2004; 10(2): 205-208 [PMID: 14716823 DOI: 10.3748/wjg.v10.i2.205] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
26 Médard G. (−)-Astrogorgiadiol: a shorter route to A-ring synthon. Tetrahedron 2013;69:2348-51. [DOI: 10.1016/j.tet.2012.12.087] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M. Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med 2015;7:1-10. [PMID: 25926760 DOI: 10.2147/HMER.S50161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
28 Le Guillou S, Sdassi N, Laubier J, Passet B, Vilotte M, Castille J, Laloë D, Polyte J, Bouet S, Jaffrézic F. Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution. PLoS One. 2012;7:e45727. [PMID: 23029204 DOI: 10.1371/journal.pone.0045727] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
29 Wang JL, Nong LG, Tang YJ, Wei YS, Yang FL, Wang CF. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma. Med Oncol 2014;31:20. [PMID: 24913806 DOI: 10.1007/s12032-014-0020-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Strino F, Parisi F, Kluger Y. VDA, a method of choosing a better algorithm with fewer validations. PLoS One 2011;6:e26074. [PMID: 22046256 DOI: 10.1371/journal.pone.0026074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Dalla-Torre CA, Yoshimoto M, Lee CH, Joshua AM, de Toledo SR, Petrilli AS, Andrade JA, Chilton-MacNeill S, Zielenska M, Squire JA. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma. BMC Cancer 2006;6:237. [PMID: 17022822 DOI: 10.1186/1471-2407-6-237] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
32 Zhang J, Yamada O, Kida S, Matsushita Y, Hattori T. Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-β. Cell Oncol (Dordr) 2016;39:119-28. [PMID: 26584547 DOI: 10.1007/s13402-015-0257-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
33 Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chen CJ, Chi NH, Chen GH, Lin JT. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut. 2007;56:782-789. [PMID: 17148500 DOI: 10.1136/gut.2006.109868] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
34 Zhang F, Luo W, Li Y, Gao S, Lei G. Role of osteopontin in rheumatoid arthritis. Rheumatol Int 2015;35:589-95. [PMID: 25163663 DOI: 10.1007/s00296-014-3122-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
35 Kang KH. Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics. J Korean Surg Soc 2013;84:9-17. [PMID: 23323230 DOI: 10.4174/jkss.2013.84.1.9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Lin J, Myers AL, Wang Z, Nancarrow DJ, Ferrer-Torres D, Handlogten A, Leverenz K, Bao J, Thomas DG, Wang TD, Orringer MB, Reddy RM, Chang AC, Beer DG, Lin L. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma. Oncotarget 2015;6:22239-57. [PMID: 26068949 DOI: 10.18632/oncotarget.4161] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
37 Li Y, Li L, Wang JT, Kan X, Lu JG. Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis. Med Oncol 2012;29:1429-34. [PMID: 21706367 DOI: 10.1007/s12032-011-0012-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
38 Hu H, Liu Z, Liu C. Correlation of OPN gene expression with proliferation and apoptosis of ovarian cancer cells and prognosis of patients. Oncol Lett 2019;17:2788-94. [PMID: 30854053 DOI: 10.3892/ol.2019.9896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Deangelis T, Quong A, Morrione A, Baserga R. Growth of v-src-transformed cells in serum-free medium through the induction of growth factors. J Cell Physiol 2013;228:1482-6. [PMID: 23254450 DOI: 10.1002/jcp.24303] [Reference Citation Analysis]
40 Gu M, Zheng X. Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer. Onco Targets Ther 2017;10:4121-7. [PMID: 28860821 DOI: 10.2147/OTT.S129414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Yu X, Li Z, Wu WK. TIP30: A Novel Tumor-Suppressor Gene. Oncol Res 2014;22:339-48. [PMID: 26629947 DOI: 10.3727/096504015X14424348426116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
42 Honda M, Kimura C, Uede T, Kon S. Neutralizing antibody against osteopontin attenuates non-alcoholic steatohepatitis in mice. J Cell Commun Signal 2020;14:223-32. [PMID: 32062834 DOI: 10.1007/s12079-020-00554-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Anwar A, Li M, Frid MG, Kumar B, Gerasimovskaya EV, Riddle SR, McKeon BA, Thukaram R, Meyrick BO, Fini MA, Stenmark KR. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2012;303:L1-L11. [PMID: 22582113 DOI: 10.1152/ajplung.00050.2012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
44 Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer. Gastric Cancer. 2015; Epub ahead of print. [PMID: 26681196 DOI: 10.1007/s10120-015-0583-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
45 Bache M, Kappler M, Wichmann H, Rot S, Hahnel A, Greither T, Said HM, Kotzsch M, Würl P, Taubert H, Vordermark D. Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. BMC Cancer 2010;10:132. [PMID: 20377868 DOI: 10.1186/1471-2407-10-132] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
46 Qin L. Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies. Front Med. 2014;8:24-32. [PMID: 24464486 DOI: 10.1007/s11684-014-0312-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
47 Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal. 2011;5:111-122. [PMID: 21516514 DOI: 10.1007/s12079-011-0130-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 7.1] [Reference Citation Analysis]
48 Sawyer AJ, Kyriakides TR. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev 2016;97:56-68. [PMID: 26763408 DOI: 10.1016/j.addr.2015.12.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
49 Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, Wu GH, Luk JM. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 2012; 18(30): 3923-3930 [PMID: 22912540 DOI: 10.3748/wjg.v18.i30.3923] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
50 Zhao Y, Zhang L, Mao Z, Zhang Y, Su X, Cao Y, Tang P. The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study. Med Sci Monit 2015;21:3875-9. [PMID: 26656246 DOI: 10.12659/msm.895472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Sharma P, Kumar S, Kundu GC. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer 2010;9:178. [PMID: 20609221 DOI: 10.1186/1476-4598-9-178] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
52 Denhardt DT, Mistretta D, Chambers AF, Krishna S, Porter JF, Raghuram S, Rittling SR. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin Exp Metastasis 2003;20:77-84. [PMID: 12650610 DOI: 10.1023/a:1022550721404] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
53 Jin Y, Chen JN, Feng ZY, Zhang ZG, Fan WZ, Wang Y, Li JP. OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma. PLoS One. 2014;9:e87930. [PMID: 24498405 DOI: 10.1371/journal.pone.0087930] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
54 Bjelobaba I, Janjic MM, Prévide RM, Abebe D, Kucka M, Stojilkovic SS. Distinct Expression Patterns of Osteopontin and Dentin Matrix Protein 1 Genes in Pituitary Gonadotrophs. Front Endocrinol (Lausanne) 2019;10:248. [PMID: 31057484 DOI: 10.3389/fendo.2019.00248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Mi Z, Guo H, Kuo PC. Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer. BMC Res Notes 2009;2:119. [PMID: 19570203 DOI: 10.1186/1756-0500-2-119] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
56 Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer. 2007;7:64. [PMID: 17430594 DOI: 10.1186/1471-2407-7-64] [Cited by in Crossref: 334] [Cited by in F6Publishing: 311] [Article Influence: 22.3] [Reference Citation Analysis]
57 Zhang A, Liu Y, Shen Y, Xu Y, Li X. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells. Med Oncol 2010;27:1179-84. [PMID: 19921477 DOI: 10.1007/s12032-009-9356-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
58 Nakamura KD, Tilli TM, Wanderley JL, Palumbo A Jr, Mattos RM, Ferreira AC, Klumb CE, Nasciutti LE, Gimba ER. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells. Tumour Biol 2016;37:2655-63. [PMID: 26404131 DOI: 10.1007/s13277-015-4095-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
59 Mbeunkui F, Johann DJ. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol. 2009;63:571-582. [PMID: 19083000 DOI: 10.1007/s00280-008-0881-9] [Cited by in Crossref: 282] [Cited by in F6Publishing: 260] [Article Influence: 20.1] [Reference Citation Analysis]
60 Ferrari D, Codecà C, Fiore J, Moneghini L, Bosari S, Foa P. Biomolecular markers in cancer of the tongue. J Oncol 2009;2009:412908. [PMID: 19696947 DOI: 10.1155/2009/412908] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
61 Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037-2044. [PMID: 20597997 DOI: 10.1111/j.1582-4934.2010.01115.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 9.7] [Reference Citation Analysis]
62 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
63 Valcz G, Sipos F, Krenács T, Molnár J, Patai AV, Leiszter K, Tóth K, Solymosi N, Galamb O, Molnár B, Tulassay Z. Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence. Pathol Oncol Res 2010;16:541-5. [PMID: 20349162 DOI: 10.1007/s12253-010-9260-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
64 You Y, Zheng Q, Dong Y, Wang Y, Zhang L, Xue T, Xie X, Hu C, Wang Z, Chen R, Wang Y, Cui J, Ren Z. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway. PLoS One 2015;10:e0134243. [PMID: 26280346 DOI: 10.1371/journal.pone.0134243] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
65 Ramachandran S, Kwon KY, Shin SJ, Kwon SH, Cha SD, Lee HG, Hong YB, Bae I, Lee GH, Cho CH. Regulatory role of osteopontin in malignant transformation of endometrial cancer. Mol Biol Rep 2013;40:3623-9. [PMID: 23269624 DOI: 10.1007/s11033-012-2436-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
66 Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 2003;14:173-89. [PMID: 12529435 DOI: 10.1091/mbc.e02-06-0354] [Cited by in Crossref: 169] [Cited by in F6Publishing: 101] [Article Influence: 8.9] [Reference Citation Analysis]
67 Guarneri C, Bevelacqua V, Polesel J, Falzone L, Cannavò PS, Spandidos DA, Malaponte G, Libra M. NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma. Oncol Rep 2017;37:737-46. [PMID: 28075446 DOI: 10.3892/or.2017.5362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
68 Nazneen F, Bai F. The Roles of Osteopontin in the Pathogenesis of West Nile Encephalitis. Vaccines (Basel) 2020;8:E748. [PMID: 33317005 DOI: 10.3390/vaccines8040748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Mandelin J, Lin EC, Hu DD, Knowles SK, Do KA, Wang X, Sage EH, Smith JW, Arap W, Pasqualini R. Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin. Cancer 2009;115:1753-64. [PMID: 19224553 DOI: 10.1002/cncr.24170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
70 Zhao B, Sun T, Meng F, Qu A, Li C, Shen H, Jin Y, Li W. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer. J Cancer Res Clin Oncol. 2011;137:1061-1070. [PMID: 21207061 DOI: 10.1007/s00432-010-0968-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
71 Kimura K, Nakano T, Park YB, Tani M, Tsuda H, Beppu Y, Moriya H, Yokota J. Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma. Clin Exp Metastasis 2002;19:477-85. [PMID: 12405284 DOI: 10.1023/a:1020395816633] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
72 Masloub SM, Abdel-Azim AM, Elhamid ES. CD10 and osteopontin expression in dentigerous cyst and ameloblastoma. Diagn Pathol 2011;6:44. [PMID: 21609487 DOI: 10.1186/1746-1596-6-44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
73 Mardani M, Andisheh-Tadbir A, Khademi B, Fattahi MJ, Shafiee S, Asad-Zadeh M. Serum levels of osteopontin as a prognostic factor in patients with oral squamous cell carcinoma. Tumour Biol 2014;35:3827-9. [PMID: 24338767 DOI: 10.1007/s13277-013-1506-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
74 Imano M, Satou T, Itoh T, Sakai K, Ishimaru E, Yasuda A, Peng YF, Shinkai M, Akai F, Yasuda T. Immunohistochemical expression of osteopontin in gastric cancer. J Gastrointest Surg. 2009;13:1577-1582. [PMID: 19582521 DOI: 10.1007/s11605-009-0955-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
75 Al-Asadi MG, Brindle G, Castellanos M, May ST, Mills KI, Russell NH, Seedhouse CH, Pallis M. A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells. Oncotarget 2017;8:111405-18. [PMID: 29340063 DOI: 10.18632/oncotarget.22808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
76 Jullienne A, Hamer M, Haddad E, Morita A, Gifford P, Hartman R, Pearce WJ, Tang J, Zhang JH, Obenaus A. Acute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics. J Neurosci Res 2020;98:141-54. [PMID: 30892744 DOI: 10.1002/jnr.24405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Emani S, Zhang J, Guo L, Guo H, Kuo PC. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer. Surgery. 2008;143:803-812. [PMID: 18549897 DOI: 10.1016/j.surg.2008.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
78 Reufsteck C, Lifshitz-Shovali R, Zepp M, Bäuerle T, Kübler D, Golomb G, Berger MR. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions. Clin Exp Metastasis. 2012;29:441-456. [PMID: 22407340 DOI: 10.1007/s10585-012-9462-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
79 Boldrini L, Donati V, Dell'Omodarme M, Prati MC, Faviana P, Camacci T, Lucchi M, Mussi A, Santoro M, Basolo F. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. Br J Cancer. 2005;93:453-457. [PMID: 16091764 DOI: 10.1038/sj.bjc.6602715] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
80 Chong HC, Tan CK, Huang RL, Tan NS. Matricellular proteins: a sticky affair with cancers. J Oncol 2012;2012:351089. [PMID: 22481923 DOI: 10.1155/2012/351089] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]